• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状传播呼吁实施零新冠病毒战略以结束当前的全球危机。

Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis.

机构信息

Department of Geriatric Medicine, Huadong Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

Shanghai Key Laboratory of Clinical Geriatric Medicine, Huadong Hospital, Shanghai, China.

出版信息

Front Cell Infect Microbiol. 2022 Apr 19;12:836409. doi: 10.3389/fcimb.2022.836409. eCollection 2022.

DOI:10.3389/fcimb.2022.836409
PMID:35521224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9062041/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has led to unprecedented global challenges. A zero-COVID strategy is needed to end the crisis, but there is a lack of biological evidence. In the present study, we collected available data on SARS, MERS, and COVID-19 to perform a comprehensive comparative analysis and visualization. The study results revealed that the fatality rate of COVID-19 is low, whereas its death toll is high compared to SARS and MERS. Moreover, COVID-19 had a higher asymptomatic rate. In particular, COVID-19 exhibited unique asymptomatic transmissibility. Further, we developed a foolproof operating software in Python language to simulate COVID-19 spread in Wuhan, showing that the cumulative cases of existing asymptomatic spread would be over 100 times higher than that of only symptomatic spread. This confirmed the essential role of asymptomatic transmissibility in the uncontrolled global spread of COVID-19, which enables the necessity of implementing the zero-COVID policy. In conclusion, we revealed the triggering role of the asymptomatic transmissibility of COVID-19 in this unprecedented global crisis, which offers support to the zero-COVID strategy against the recurring COVID-19 spread.

摘要

2019 年冠状病毒病(COVID-19)大流行带来了前所未有的全球挑战。需要采取“零新冠”策略来结束这场危机,但目前缺乏生物学证据。在本研究中,我们收集了 SARS、MERS 和 COVID-19 的现有数据,以进行全面的比较分析和可视化。研究结果表明,与 SARS 和 MERS 相比,COVID-19 的病死率较低,但死亡人数较高。此外,COVID-19 的无症状感染率较高。特别是,COVID-19 表现出独特的无症状传染性。此外,我们用 Python 语言开发了一款可靠的操作软件,以模拟 COVID-19 在武汉的传播情况,结果表明,现有的无症状传播的累计病例数将比仅出现症状的传播高出 100 多倍。这证实了无症状传播在 COVID-19 全球失控传播中的重要作用,这使得实施“零新冠”政策成为必要。总之,我们揭示了 COVID-19 无症状传播在这场前所未有的全球危机中的触发作用,为应对 COVID-19 反复传播的“零新冠”策略提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/6b84c7688ab2/fcimb-12-836409-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/a2491d19e726/fcimb-12-836409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/03b8c1e54525/fcimb-12-836409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/b84e31c0c9a7/fcimb-12-836409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/5b17043aa462/fcimb-12-836409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/4915a1bc1450/fcimb-12-836409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/6b84c7688ab2/fcimb-12-836409-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/a2491d19e726/fcimb-12-836409-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/03b8c1e54525/fcimb-12-836409-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/b84e31c0c9a7/fcimb-12-836409-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/5b17043aa462/fcimb-12-836409-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/4915a1bc1450/fcimb-12-836409-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/659f/9062041/6b84c7688ab2/fcimb-12-836409-g006.jpg

相似文献

1
Asymptomatic Transmissibility Calls for Implementing a Zero-COVID Strategy to End the Current Global Crisis.无症状传播呼吁实施零新冠病毒战略以结束当前的全球危机。
Front Cell Infect Microbiol. 2022 Apr 19;12:836409. doi: 10.3389/fcimb.2022.836409. eCollection 2022.
2
Asymptomatic Transmission During the Coronavirus Disease 2019 Pandemic and Implications for Public Health Strategies.新型冠状病毒肺炎大流行期间的无症状传播及其对公共卫生策略的影响。
Clin Infect Dis. 2020 Dec 17;71(10):2752-2756. doi: 10.1093/cid/ciaa654.
3
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
4
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19.无症状SARS-CoV-2感染的高流行率揭示了COVID-19的隐性传播。
Int J Infect Dis. 2021 Apr;105:656-661. doi: 10.1016/j.ijid.2021.02.100. Epub 2021 Feb 26.
5
The Coronavirus Pandemic: What Does the Evidence Show?新冠疫情:证据表明了什么?
J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596.
6
The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.SARS-CoV-2 变异株的出现及其对黎巴嫩纳巴提耶地区 COVID-19 病例流行的影响。
Med Sci (Basel). 2021 Jun 2;9(2):40. doi: 10.3390/medsci9020040.
7
An Analysis of 38 Pregnant Women With COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes.分析 38 例 COVID-19 孕妇、其新生儿和 SARS-CoV-2 的母婴传播:冠状病毒感染与妊娠结局。
Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805. doi: 10.5858/arpa.2020-0901-SA.
8
Transmission roles of symptomatic and asymptomatic COVID-19 cases: a modelling study.有症状和无症状 COVID-19 病例的传播作用:一项建模研究。
Epidemiol Infect. 2022 Sep 27;150:e171. doi: 10.1017/S0950268822001467.
9
SARS-CoV-2: a new dimension to our understanding of coronaviruses.SARS-CoV-2:对冠状病毒认识的新维度。
Int Microbiol. 2021 Jan;24(1):19-24. doi: 10.1007/s10123-020-00152-y. Epub 2020 Nov 24.
10
Challenges of managing the asymptomatic carriers of SARS-CoV-2.管理无症状 SARS-CoV-2 携带者面临的挑战。
Travel Med Infect Dis. 2020 Sep-Oct;37:101677. doi: 10.1016/j.tmaid.2020.101677. Epub 2020 Apr 18.

引用本文的文献

1
SARS-CoV-2-infected human airway epithelial cell cultures uniquely lack interferon and immediate early gene responses caused by other coronaviruses.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的人气道上皮细胞培养物独特地缺乏由其他冠状病毒引起的干扰素和立即早期基因反应。
Clin Transl Immunology. 2024 Apr 15;13(4):e1503. doi: 10.1002/cti2.1503. eCollection 2024.
2
Deciphering GABBR1-centered drug targets to fight viral infection with preexisting diabetes.解析以GABBR1为中心的药物靶点以对抗合并糖尿病时的病毒感染。
Acta Biochim Biophys Sin (Shanghai). 2023 Dec 25;55(12):1999-2003. doi: 10.3724/abbs.2023249.
3
Developing drugs targeting CX3CL1 to treat heart diseases via immune/inflammatory mediation.

本文引用的文献

1
'Zero COVID' is getting harder-but China is sticking with it.“动态清零”正变得更加艰难——但中国仍在坚持。
Science. 2021 Nov 19;374(6570):924. doi: 10.1126/science.acx9657. Epub 2021 Nov 18.
2
Historic opportunity: artificial intelligence interventions in COVID-19 and other unknown diseases.历史性机遇:人工智能在新冠疫情及其他未知疾病中的干预措施
Acta Biochim Biophys Sin (Shanghai). 2021 Nov 10;53(11):1575-1577. doi: 10.1093/abbs/gmab120.
3
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization.SARS-CoV-2 变异株 P.1 对抗体中和的抵抗力增强。
开发靶向CX3CL1的药物,通过免疫/炎症介导来治疗心脏病。
Acta Biochim Biophys Sin (Shanghai). 2023 Oct 25;55(10):1672-1676. doi: 10.3724/abbs.2023157.
4
Collective and Individual Assessment of the Risk of Death from COVID-19 for the Elderly, 2020-2022.2020 - 2022年老年人因新型冠状病毒肺炎死亡风险的集体与个体评估
China CDC Wkly. 2023 May 5;5(18):407-412. doi: 10.46234/ccdcw2023.077.
5
The Advantages of the Zero-COVID-19 Strategy.中国“动态清零”总方针的优势
Int J Environ Res Public Health. 2022 Jul 19;19(14):8767. doi: 10.3390/ijerph19148767.
Cell Host Microbe. 2021 May 12;29(5):747-751.e4. doi: 10.1016/j.chom.2021.04.007. Epub 2021 Apr 18.
4
K-SEIR-Sim: A simple customized software for simulating the spread of infectious diseases.K-SEIR-Sim:一款用于模拟传染病传播的简单定制软件。
Comput Struct Biotechnol J. 2021;19:1966-1975. doi: 10.1016/j.csbj.2021.04.004. Epub 2021 Apr 7.
5
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.SARS-CoV-2 变体 B.1.351 从自然和疫苗诱导的血清中逃逸的证据。
Cell. 2021 Apr 29;184(9):2348-2361.e6. doi: 10.1016/j.cell.2021.02.037. Epub 2021 Feb 23.
6
The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity.不同疾病严重程度的 COVID-19 患者的二分法和不完全适应性免疫。
Signal Transduct Target Ther. 2021 Mar 8;6(1):113. doi: 10.1038/s41392-021-00525-3.
7
Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS.重新发现咖啡因:一种既能改善患者预后,又能对抗战争的绝佳药物。
Curr Med Chem. 2021;28(27):5449-5462. doi: 10.2174/0929867327666201103162810.
8
Achieving zero covid is not easy, but the alternative is far worse.实现新冠清零并不容易,但不这样做的后果要糟糕得多。
BMJ. 2020 Oct 7;371:m3859. doi: 10.1136/bmj.m3859.
9
Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach.印度控制 2019 年冠状病毒病传播的谨慎公共卫生干预策略:基于数学模型的方法。
Indian J Med Res. 2020;151(2 & 3):190-199. doi: 10.4103/ijmr.IJMR_504_20.
10
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.新冠病毒、中东呼吸综合征病毒和严重急性呼吸综合征病毒在非人灵长类动物模型中的比较发病机制。
Science. 2020 May 29;368(6494):1012-1015. doi: 10.1126/science.abb7314. Epub 2020 Apr 17.